April 26, 2017
UC San Diego announced its first eight proof-of-concept awards to advance university inventions to commercial impact. Funded through the new “Accelerating Innovations to Market (AIM)” program, these milestone-driven projects are designed to de-risk early-stage technologies.
May 22, 2017
Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse. Yet apart from alcohol abstinence, there are no specific treatments to reduce the severity of alcohol-associated liver disease. Researchers at University of California San Diego School of Medicine and…
August 7, 2019
In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.
September 11, 2019
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
December 17, 2019
In a UC San Diego study, rats with spinal cord injuries experienced a three-fold increase in motor activity when treated with neural progenitor cells that had been pre-conditioned with a modified form of tPA, a drug commonly used to treat non-hemorrhagic stroke.
February 6, 2020
Researchers from University of California San Diego School of Medicine have defined the most detailed list of genetic fingerprints of DNA-damaging processes that drive cancer development to date.
February 18, 2021
UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.
July 21, 2021
UC San Diego is one of six universities invited to participate in the Wu Tsai Human Performance Alliance, a scientific collaboration that aims to transform human health on a global scale through the discovery and translation of the biological principles underlying human performance.
February 10, 2022
The Olav Thon Foundation in Norway has announced that Anders M. Dale, PhD, professor of Neurosciences, Radiology, Psychiatry, Cognitive Science, and Data Science at UC San Diego, is the recipient of its 2022 international research prize within the natural sciences and medicine.
February 14, 2022
New heart arrhythmia mapping technology debuts at UC San Diego Health.
